Abstract:Background: Brucellosis, caused by Brucella spp., is a major zoonotic public health threat. Although several Brucella vaccines have been demonstrated for use in animals, Brucella spp. can cause human infection and to date, there are no human-use vaccines licensed by any agency. Recently, methods in vaccine informatics have made major breakthroughs in peptide-based epitopes, opening up a new avenue of vaccine development. Objectives: The purpose of this article was to identify potential antigenic peptides in Brucella by proteome and peptidome analyses. Methods: Mouse infection models were first established by injection with Brucella and spleen protein profiles were then analysed. Subsequently, the major histocompatibility complex class I or II (major histocompatibility complex [MHC]-I/II)-binding peptides in blood samples were collected by immunoprecipitation and peptides derived from Brucella proteins were identified through liquid chromatography-mass spectrometry (LC-MS/MS). These peptides were then evaluated in a variety of ways, such as in terms of conservation in Brucella and synchronicity in predicted peptides (similarity and coverage), which allowed us to more effectively measure their antigenic potential. Results: The expression of the inflammatory cytokines IL1B and IFN-γ was significantly altered in the spleen of infected mice and some Brucella proteins, such as Muri, AcpP and GroES, were also detected. Meanwhile, in blood, 35 peptides were identified and most showed high conservation, highlighting their potential as antigen epitopes for vaccine development. In particular, we identified four proteins containing both MHC-I- and MHC-II-binding peptides including AtpA, AtpD, DnaK and BAbS19_II02030. They were also compared with the predicted peptides to estimate their reliability. Conclusions: The peptides we screened could bind to MHC molecules. After being stimulated with antigen T epitopes, Memory T cells can stimulate T cell activation and promote immune responses. Our results indicated that the peptides we identified may be good candidate targets for the design of subunit vaccines and these results pave the way for the study of safer vaccines against Brucella.

BacScan: An Unbiased and Genome-Wide Approach to Identify Bacterial Highly Immunogenic Proteins

BacScan: a Novel Genome-Wide Strategy for Uncovering Broadly Immunogenic Proteins in Bacteria

Identification and Evaluation of Novel Antigen Candidates Against Salmonella Pullorum Infection Using Reverse Vaccinology.

De novo identification of bacterial antigens of a clinical isolate by combining use of proteosurfaceomics, secretomics, and BacScan technologies

Pre-Absorbed Immunoproteomics: A Novel Method for the Detection of Streptococcus Suis Surface Proteins

Identification and Characterization of Novel Immunogenic Proteins of Streptococcus Suis Serotype 2

Rapid Screening of Highly Efficient Vaccine Candidates by Immunoproteomics

Evaluation of the Protective Efficacy of Four Novel Identified Membrane Associated Proteins of Streptococcus Suis Serotype 2.

Pooled Protein Immunization for Identification of Cell Surface Antigens in Streptococcus Sanguinis

Development of a Universal Multi-Epitope Vaccine Candidate Against Streptococcus Suis Infections Using Immunoinformatics Approaches

Proteomics-based vaccine targets annotation and design of multi-epitope vaccine against antibiotic-resistant Streptococcus gallolyticus

Reverse vaccinology approach for the identifications of potential vaccine candidates against Salmonella

Identification of Broad Cross-Protective Immunogens Using Heterogeneous Antiserum-Based Immunoproteomic Approach

Identification of Antigens Common to Streptococcus Suis Serotypes 2 and 9 by Immunoproteomic Analysis

Immunoproteomic assay of surface proteins of Streptococcus suis serotype 9.

Materials and methods Bacterial strains and culture conditions

Immunoproteomics of Extracellular Proteins of Chinese Virulent Strains of Streptococcus Suis Type 2

Identification of Conserved Surface Proteins As Novel Antigenic Vaccine Candidates of Actinobacillus Pleuropneumoniae

Immunoproteomic assay of secreted proteins of Streptococcus suis serotype 9 with convalescent sera from pigs

Large-scale identification of bacteria-host crosstalk by affinity chromatography: capturing the interactions of Streptococcus suis proteins with host cells.

Identification of potential antigenic peptides of Brucella through proteome and peptidome